Recovery of Corneal Innervation after Treatment in Dry Eye Disease: A Confocal Microscopy Study

Purpose: To analyze the changes in corneal innervation by means of in vivo corneal confocal microscopy (IVCM) in patients diagnosed with Evaporative (EDE) and Aqueous Deficient Dry Eye (ADDE) and treated with a standard treatment for Dry Eye Disease (DED) in combination with Plasma Rich in Growth Factors (PRGF). Methods: Eighty-three patients diagnosed with DED were enrolled in this study and included in the EDE or ADDE subtype. The primary variables analyzed were the length, density and number of nerve branches, and the secondary variables were those related to the quantity and stability of the tear film and the subjective response of the patients measured with psychometric questionnaires. Results: The combined treatment therapy with PRGF outperforms the standard treatment therapy in terms of subbasal nerve plexus regeneration, significantly increasing length, number of branches and nerve density, as well as significantly improving the stability of the tear film (p < 0.05 for all of them), and the most significant changes were located in the ADDE subtype. Conclusions: the corneal reinnervation process responds in a different way depending on the treatment prescribed and the subtype of dry eye disease. In vivo confocal microscopy is presented as a powerful technique in the diagnosis and management of neurosensory abnormalities in DED.

Automated summary

This study used in vivo corneal confocal microscopy to analyze the changes in corneal innervation in patients with Evaporative and Aqueous Deficient Dry Eye and treated with a standard treatment for Dry Eye Disease in combination with Plasma Rich in Growth Factors. The results showed that the combined treatment therapy with PRGF outperformed the standard treatment therapy in terms of subbasal nerve plexus regeneration and tear film stability, with the most significant improvement observed in the ADDE subtype.